SEC Tracker
Get the app
Person · CIK 2036234

Vanina de Verneuil

EVP at Vir Biotechnology

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$453K
Noticed on Form 144$440K
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Vir Biotechnology VIRCommon StockDirectly110,193Nov 3, 2026 · Filing · EDGAR
Vir Biotechnology VIRStock Option (Right to Buy)
exercise $7.56, expires Feb 21, 2036, into Common Stock
Directly110,000Feb 22, 2026 · Filing · EDGAR

Sold and noticed by quarter

Vanina de Verneuil: dollars sold on Form 4 and noticed on Form 144 per quarter, Q4 2024 to Q4 2026$197K$0Q4 2024: $65K noticed on Form 144Q4 2024: $77K sold on Form 4Q1 2025: $116K noticed on Form 144Q1 2025: $116K sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $20K noticed on Form 144Q4 2025: $20K sold on Form 4Q1 2026: $197K noticed on Form 144Q1 2026: $197K sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $42K noticed on Form 144Q4 2026: $42K sold on Form 4Q4 2024Q2 2025Q4 2025Q2 2026Q4 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q4 2026$42K$42K
Q1 2026$197K$197K
Q4 2025$20K$20K
Q1 2025$116K$116K
Q4 2024$77K$65K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Vir Biotechnology VIR · Fidelity Brokerage Services · 10b5-1 plan adopted May 26, 2026 · 1 notice
Nov 3, 20262,407 · ~$27KNov 3, 2026Sold as noticed Sold 2,407 at $11.10 on Nov 3 · $27K Form 4Filing · EDGAR
Vir Biotechnology VIR · Fidelity Brokerage Services · No 10b5-1 plan stated · 4 notices
Nov 2, 20261,343 · ~$15KNov 2, 2026Sold as noticed Sold 1,343 at $11.33 on Nov 2 · $15K Form 4Filing · EDGAR
Feb 24, 20263,117 · ~$30KFeb 24, 2026Sold as noticed Sold 3,117 at $9.53 on Feb 24 · $30K Form 4Filing · EDGAR
Feb 23, 20264,445 · ~$33KFeb 23, 2026Sold as noticed Sold 4,445 at $7.45 on Feb 23 · $33K Form 4Filing · EDGAR
Nov 3, 20251,365 · ~$8KNov 3, 2025Sold as noticed Sold 1,365 at $5.86 on Nov 3 · $8K Form 4Filing · EDGAR
Vir Biotechnology VIR · Fidelity Brokerage Services · 10b5-1 plan adopted Jun 2, 2025 · 2 notices
Feb 25, 202613,700 · ~$135KFeb 25, 2026Sold as noticed Sold 13,700 at $9.82 on Feb 25 · $135K Form 4Filing · EDGAR
Nov 5, 20252,385 · ~$12KNov 5, 2025Sold as noticed Sold 2,385 at $5.16 on Nov 5 · $12K Form 4Filing · EDGAR
Vir Biotechnology VIR · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 5, 2024 · 3 notices
Feb 26, 20257,373 · ~$67KFeb 26, 2025Sold as noticed Sold 7,373 at $9.14 on Feb 26 · $67K Form 4Filing · EDGAR
Nov 6, 20244,397 · ~$42KNov 6, 2024Partly sold Sold 2,347 at $9.47 on Nov 5 · $22K likely match Form 4Filing · EDGAR
Nov 5, 20242,347 · ~$22KNov 5, 2024Partly sold Sold 1,479 in 2 sales, Nov 1 to Dec 2 · $11K likely match Form 4 (1) · Form 4 (2)Filing · EDGAR
Vir Biotechnology VIR · Morgan Stanley Smith Barney · 10b5-1 plan adopted Feb 22, 2022 · 1 notice
Feb 24, 20255,140 · ~$49KFeb 24, 2025Sold as noticed Sold 5,140 at $9.45 on Feb 24 · $49K Form 4Filing · EDGAR
Vir Biotechnology VIR · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Dec 2, 202476 · ~$625Dec 2, 2024Not sold within 90 daysFiling · EDGAR
Sales without a matching Form 144 · 1 sale
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Vir Biotechnology (VIR): Sold 4,397 at $10.11 on Nov 6, 2024 · $44K (10b5-1 plan)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Vir Biotechnology VIR EVP, General Counsel, Corp Sec · filings 2024 to 2026 · sold $453K · $440K noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Nov 3, 2026Sale under a 10b5-1 plan−2,407$11.10$27K110,193 directFiling · EDGAR
Nov 2, 2026Sale under a 10b5-1 plan−1,343$11.33$15K112,600 directFiling · EDGAR
Feb 25, 2026Sale under a 10b5-1 plan−13,700$9.82$135K112,982 directFiling · EDGAR
Feb 24, 2026Sale under a 10b5-1 plan−3,117$9.53$30K126,682 directFiling · EDGAR
Feb 23, 2026Sale under a 10b5-1 plan−4,445$7.45$33K129,799 directFiling · EDGAR
Feb 22, 2026Grant or award from the company+55,000134,244 directFiling · EDGAR
Feb 22, 2026Grant or award from the company
Stock Option (Right to Buy)
+110,000110,000 directFiling · EDGAR
Nov 5, 2025Sale under a 10b5-1 plan−2,385$5.16$12K78,210 directFiling · EDGAR
Nov 3, 2025Sale under a 10b5-1 plan−1,365$5.86$8K80,595 directFiling · EDGAR
Feb 26, 2025Sale under a 10b5-1 plan−7,373$9.14$67K79,460 directFiling · EDGAR
Feb 24, 2025Sale under a 10b5-1 plan−5,140$9.45$49K86,833 directFiling · EDGAR
Feb 22, 2025Grant or award from the company+35,00091,973 directFiling · EDGAR
Feb 22, 2025Grant or award from the company
Stock Option (Right to Buy)
+70,00070,000 directFiling · EDGAR
Dec 2, 2024Open-market or private sale−76$8.22$62556,973 directFiling · EDGAR
Nov 6, 2024Sale under a 10b5-1 plan−4,397$10.11$44K56,973 directFiling · EDGAR
Nov 5, 2024Sale under a 10b5-1 plan−2,347$9.47$22K61,370 directFiling · EDGAR
Nov 1, 2024Sale under a 10b5-1 plan−1,403$7.20$10K63,717 directFiling · EDGAR
All 23 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Nov 4, 2026Form 4Vir Biotechnology VIRFiling · EDGAR
Nov 3, 2026Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 2, 2026Form 144Vir Biotechnology VIRFiling · EDGAR
Feb 26, 2026Form 4Vir Biotechnology VIRFiling · EDGAR
Feb 25, 2026Form 144Vir Biotechnology VIRFiling · EDGAR
Feb 24, 2026Form 144Vir Biotechnology VIRFiling · EDGAR
Feb 24, 2026Form 4Vir Biotechnology VIRFiling · EDGAR
Feb 23, 2026Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 7, 2025Form 4Vir Biotechnology VIRFiling · EDGAR
Nov 5, 2025Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 4, 2025Form 4Vir Biotechnology VIRFiling · EDGAR
Nov 3, 2025Form 144Vir Biotechnology VIRFiling · EDGAR
Feb 27, 2025Form 4Vir Biotechnology VIRFiling · EDGAR
Feb 26, 2025Form 144Vir Biotechnology VIRFiling · EDGAR
Feb 25, 2025Form 4Vir Biotechnology VIRFiling · EDGAR
Feb 24, 2025Form 144Vir Biotechnology VIRFiling · EDGAR
Dec 4, 2024Form 4Vir Biotechnology VIRFiling · EDGAR
Dec 2, 2024Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 7, 2024Form 4Vir Biotechnology VIRFiling · EDGAR
Nov 6, 2024Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 5, 2024Form 144Vir Biotechnology VIRFiling · EDGAR
Nov 5, 2024Form 4Vir Biotechnology VIRFiling · EDGAR
Oct 2, 2024Form 3Vir Biotechnology VIRFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.